Current state and future prospects of pharmacological interventions for autism. (April 2013)

• Record Type: Journal Article
• Authors: Vahabzadeh, Arshya; Buxton, David; McDougle, Christopher J; Stigler, Kimberly A
• Is Part Of: Neuropsychiatry. Volume 3:Number 2(2013)
• Page Start: 245
• Page End: 259
• Publication Date: 2013-04
• Subjects: Psychology, Pathological -- Periodicals; Mental illness -- Periodicals; Neuropsychiatry -- Periodicals; Mental Disorders -- Periodicals; Nervous System Diseases -- Periodicals; Neuropsychiatry -- Periodicals; Mental illness; Neuropsychiatry; Psychology, Pathological; 616.8
• DOI: 10.2217/npy.13.22
• Languages: English
• ISSNs: 1758-2008

Abstract

SUMMARY Autism spectrum disorder (ASD) is a group of heterogeneous developmental disorders manifesting in early childhood. They are associated with a range of core and associated symptoms, including repetitive behaviors, hyperactivity and irritability. This review will describe the current evidence for psychopharmacological management of individuals with ASD. Additionally, some of the future treatment prospects will be discussed. Safety issues, adverse effects and limitations of the current literature will also be highlighted.